Sign in →

Test ID BLOD1222 Thiopurine Methyltransferase Activity Profile, Erythrocytes

Useful For

Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs

 

Detection of individuals with hyperactive TPMT activity who have therapeutic resistance to thiopurine drugs and may develop hepatotoxicity if treated with these drugs

Specimen Type

Whole blood


Specimen Required


Patient Preparation: Thiopurine methyltransferase (TPMT) enzyme activity can be inhibited by several drugs and may contribute to falsely low results. Patients should abstain from the following drugs for at least 48 hours prior to TPMT testing: naproxen (Aleve), ibuprofen (Advil, Motrin), ketoprofen (Orudis), furosemide (Lasix), sulfasalazine (Azulfidine), mesalamine (Asacol), olsalazine (Dipentum), mefenamic acid (Ponstel), trimethoprim (Proloprim), methotrexate, thiazide diuretics, and benzoic acid inhibitors.

Container/Tube:

Preferred: Lavender top (EDTA)

Acceptable: Green top (sodium or lithium heparin), dark blue top (metal free sodium heparin), or plasma gel tubes

Specimen Volume: 5 mL


Reject Due To

Gross hemolysis Reject

Specimen Minimum Volume

3 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Whole blood Refrigerated (preferred) 6 days
  Ambient  6 days

Day(s) Performed

Monday, Wednesday, Friday

Report Available

4 to 7 days

Method Name

Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

84433

Reporting Name

TPMT Activity Profile, RBC

Reference Values

6-Methylmercaptopurine (normal): 3.00-6.66 nmol/mL/hour

6-Methylmercaptopurine riboside (normal): 5.04-9.57 nmol/mL/hour

6-Methylthioguanine riboside (normal): 2.70-5.84 nmol/mL/hour

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

Forms

1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:

-Informed Consent for Genetic Testing (T576)

-Informed Consent for Genetic Testing-Spanish (T826)

2. If not ordering electronically, complete, print, and send Gastroenterology and Hepatology Test Request (T728) with the specimen

Secondary ID

65188
Sanford Laboratories - Sioux Falls/Rapid City Additional Information:

SANFORD LABORATORY INTERFACE BUILD INFORMATION

Result Code  Result Code Description 
23732 Interpretation
23733 6-Methylmercaptopurine
23734 6-Methylmerfaptopurine Riboside
23735 6-Methylthioguanine Riboside
23736 Reviewed By